Advertisement
Screener

EyePoint, Inc. (EYPT) Increase (Decrease) in Other Noncurrent Assets

2.8 / 5 stars · 68/120 Roast Me

EyePoint, Inc. Increase (Decrease) in Other Noncurrent Assets

EyePoint, Inc. (EYPT) reported Increase (Decrease) in Other Noncurrent Assets of $3.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05

  • EyePoint, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $64.00K, a 255.56% increase year-over-year.
  • EyePoint, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $3.36M, a 7534.09% increase year-over-year.
  • EyePoint, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $27.00K, a 99.21% decline year-over-year.
  • EyePoint, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $24.00K, a 99.01% decline year-over-year.
  • EyePoint, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $113.00K, a 98.06% decline from fiscal 2024.
  • EyePoint, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $5.83M.
  • EyePoint, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
Period endIncrease (Decrease) in Other Noncurrent Assets 3 monthIncrease (Decrease) in Other Noncurrent Assets 6 monthIncrease (Decrease) in Other Noncurrent Assets 9 monthIncrease (Decrease) in Other Noncurrent Assets 12 month
2026-06-30$64.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$3.42M
10-Q · filed 2026-08-05
$3.45M
derived: sum of 3 quarters · filed 2026-08-05
$3.47M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$3.36M
10-Q · filed 2026-05-07
$3.39M
derived: sum of 2 quarters · filed 2026-05-07
$3.41M
derived: sum of 3 quarters · filed 2026-05-07
$3.43M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$51.00K
derived: sum of 2 quarters · filed 2026-03-05
$69.00K
derived: sum of 3 quarters · filed 2026-08-05
$113.00K
10-K · filed 2026-03-05
2025-09-30$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$42.00K
derived: sum of 2 quarters · filed 2026-08-05
$86.00K
10-Q · filed 2025-11-06
$3.50M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$62.00K
10-Q · filed 2026-08-05
$3.47M
derived: sum of 3 quarters · filed 2026-08-05
$5.89M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$44.00K
10-Q · filed 2026-05-07
$3.45M
derived: sum of 2 quarters · filed 2026-05-07
$5.88M
derived: sum of 3 quarters · filed 2026-05-07
$5.88M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$3.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$5.83M
derived: sum of 2 quarters · filed 2026-03-05
$5.83M
derived: sum of 3 quarters · filed 2026-03-05
$5.83M
10-K · filed 2026-03-05
2024-09-30$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$2.42M
derived: sum of 2 quarters · filed 2025-11-06
$2.42M
10-Q · filed 2025-11-06
$2.42M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2025-08-07
2024-03-31$0.00
10-Q · filed 2025-05-08
$0.00
derived: sum of 2 quarters · filed 2025-05-08
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$0.00
10-K · filed 2025-03-06
2023-09-30$0.00
10-Q · filed 2024-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15